David Robertson to HIV-1
This is a "connection" page, showing publications David Robertson has written about HIV-1.
Connection Strength
1.023
-
Jiang X, Feyertag F, Meehan CJ, McCormack GP, Travers SA, Craig C, Westby M, Lewis M, Robertson DL. Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor. J Virol. 2015 Nov; 89(22):11457-72.
Score: 0.326
-
Sugrue E, Wickenhagen A, Mollentze N, Aziz MA, Sreenu VB, Truxa S, Tong L, da Silva Filipe A, Robertson DL, Hughes J, Rihn SJ, Wilson SJ. The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness. PLoS Pathog. 2022 11; 18(11):e1010973.
Score: 0.134
-
Lewis M, Mori J, Toma J, Mosley M, Huang W, Simpson P, Mansfield R, Craig C, van der Ryst E, Robertson DL, Whitcomb JM, Westby M. Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials. PLoS One. 2018; 13(12):e0204099.
Score: 0.102
-
Alessandri-Gradt E, De Oliveira F, Leoz M, Lemee V, Robertson DL, Feyertag F, Ngoupo PA, Mauclere P, Simon F, Plantier JC. HIV-1 group P infection: towards a dead-end infection? AIDS. 2018 06 19; 32(10):1317-1322.
Score: 0.099
-
Leoz M, Feyertag F, Kfutwah A, Maucl?re P, Lachenal G, Damond F, De Oliveira F, Lem?e V, Simon F, Robertson DL, Plantier JC. The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon. PLoS Pathog. 2015 Aug; 11(8):e1005029.
Score: 0.081
-
Bartlett AD, MaCartney MJ, Conibear TC, Feyertag F, Smith CJ, Johnson MA, Hyams C, Garcia-Diaz A, McCormick AL, Booth C, Robertson DL, Webster DP. The utility of different bioinformatics algorithms for genotypic HIV-1 tropism testing in a large clinical cohort with multiple subtypes. AIDS. 2014 Jul 17; 28(11):1611-7.
Score: 0.075
-
Gibson RM, Meyer AM, Winner D, Archer J, Feyertag F, Ruiz-Mateos E, Leal M, Robertson DL, Schmotzer CL, Qui?ones-Mateu ME. Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism. Antimicrob Agents Chemother. 2014; 58(4):2167-85.
Score: 0.073
-
Simon-Loriere E, Galetto R, Hamoudi M, Archer J, Lefeuvre P, Martin DP, Robertson DL, Negroni M. Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog. 2009 May; 5(5):e1000418.
Score: 0.053
-
Baird HA, Galetto R, Gao Y, Simon-Loriere E, Abreha M, Archer J, Fan J, Robertson DL, Arts EJ, Negroni M. Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res. 2006; 34(18):5203-16.
Score: 0.044
-
Apetrei C, Descamps D, Collin G, Robertson DL, Pandrea I, Groza P, Prisecariu L, Teodorescu I, Luca V, Brun-V?zinet F. HIV type 1 diversity in northeastern Romania in 200-2001 based on phylogenic analysis of pol sequences from patient failing antiretroviral therapy. AIDS Res Hum Retroviruses. 2003 Dec; 19(12):1155-1161.
Score: 0.036